California Public Employees Retirement System’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49M Sell
182,541
-56,922
-24% -$2.06M ﹤0.01% 964
2026
Q1
$7.3M Buy
239,463
+8,452
+4% +$279K ﹤0.01% 962
2025
Q4
$8.29M Sell
231,011
-3,237
-1% -$98.8K ﹤0.01% 950
2025
Q3
$5.65M Buy
+234,248
New +$4.9M ﹤0.01% 1039

Other funds holding INDV

California Public Employees Retirement System's INDV Position: Q2 2026 in Review

California Public Employees Retirement System reduced its Indivior Pharmaceuticals (INDV) stake by 24% in Q2 2026, selling an estimated $2.06M and leaving 182,541 shares worth $7.49M. The position accounts for ﹤0.01% of the portfolio, ranked #964.

California Public Employees Retirement System first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.29M in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • California Public Employees Retirement System held 182,541 shares of Indivior Pharmaceuticals worth $7.49M as of Q2 2026.
  • California Public Employees Retirement System sold 56,922 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.06M.
  • Indivior Pharmaceuticals made up ﹤0.01% of California Public Employees Retirement System's portfolio in Q2 2026, its #964 holding.
  • California Public Employees Retirement System first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • California Public Employees Retirement System's Indivior Pharmaceuticals position peaked at $8.29M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on California Public Employees Retirement System's 13F filing for Q2 2026, filed 14 Aug 2026.